We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.81B
AUM Growth
–
Cap. Flow
+$6.65B
Cap. Flow %
97.72%
Top 10 Hldgs %
62.98%
Holding
122
New
122
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$643M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$511M
3
GILD icon
Gilead Sciences
GILD
+$449M
4
UNP icon
Union Pacific
UNP
+$448M
5
MSFT icon
Microsoft
MSFT
+$425M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 33.15%
2 Healthcare 19.91%
3 Communication Services 17.51%
4 Consumer Discretionary 10.23%
5 Industrials 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASXC
76
DELISTED
Asensus Surgical, Inc.
ASXC
$2.11M 0.03%
+38,462
New +$2.07M
FMS icon
77
Fresenius Medical Care
FMS
$13.4B
$2.01M 0.03%
+57,900
New +$2M
TTPH
78
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2M 0.03%
+5,000
New +$1.34M
TEVA icon
79
Teva Pharmaceuticals
TEVA
$40.4B
$1.94M 0.03%
+36,000
New +$1.91M
ALXA
80
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$1.72M 0.03%
+715,580
New +$2.73M
EGRX
81
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.72M 0.03%
+140,000
New +$1.74M
SRNE
82
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.69M 0.02%
+370,000
New +$1.99M
TVRD
83
Tvardi Therapeutics
TVRD
$20.1M
$1.67M 0.02%
+5,594
New +$2.3M
AEGR
84
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.51M 0.02%
+45,000
New +$1.4M
REGN icon
85
Regeneron Pharmaceuticals
REGN
$72.9B
$1.43M 0.02%
+4,050
New +$1.36M
LUMO
86
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.41M 0.02%
+7,000
New +$1.54M
PTLA
87
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.36M 0.02%
+52,932
New +$1.39M
INVA icon
88
Innoviva
INVA
$1.6B
$1.33M 0.02%
+76,500
New +$1.76M
KTWO
89
DELISTED
K2M Group Holdings, Inc
KTWO
$1.29M 0.02%
+100,000
New +$1.5M
CARM
90
DELISTED
Carisma Therapeutics
CARM
$1.16M 0.02%
+5,000
New +$1.19M
CRDF icon
91
Cardiff Oncology
CRDF
$63M
$1.13M 0.02%
+3,472
New +$1.04M
QIWI
92
DELISTED
QIWI PLC
QIWI
$903K 0.01%
+28,575
New +$1.07M
OXFD
93
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$898K 0.01%
+60,000
New +$919K
INNL
94
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$835K 0.01%
+125,000
New +$1.02M
LMNS
95
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$723K 0.01%
+80,604
New +$738K
NBIS
96
Nebius Group N.V.
NBIS
$37.6B
$701K 0.01%
+25,200
New +$764K
TBPH icon
97
Theravance Biopharma
TBPH
$873M
$518K 0.01%
+21,857
New +$634K
ARCT icon
98
Arcturus Therapeutics
ARCT
$165M
$380K 0.01%
+3,514
New +$458K
XLRN
99
DELISTED
Acceleron Pharma
XLRN
$312K ﹤0.01%
+10,500
New +$296K
BCE icon
100
BCE
BCE
$20.8B
$302K ﹤0.01%
+6,300
New +$281K
1 2 3
4
5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q3 2014 Portfolio in Review

Q3 2014 is the first quarter with a 13F filing on record for C WorldWide Group, which disclosed 122 positions worth $6.81B. Its ten largest holdings account for 63% of the portfolio.

Its largest position is Visa: 11,971,640 shares worth $639M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, followed by Healthcare and Communication Services.

  • C WorldWide Group's largest Q3 2014 buy was Visa: 11,971,640 shares worth $639M.
  • C WorldWide Group's ten largest holdings make up 63% of its $6.81B portfolio in Q3 2014.
  • C WorldWide Group disclosed 122 positions in Q3 2014, its first 13F filing on record.

Based on C WorldWide Group's 13F filing for Q3 2014, filed 14 Nov 2014.